The approval of esketamine, known as Spravato, for use against severe depression is special -- it is saving lives.
In its first report on cannabis companies, Melius says prices are high.
Don't try to fight the market trend, work with it -- but keep an eye to the news and be ready to act.
And why I won't recommend any other stocks in these markets, right now.
Between options expiry and seasonality, March is a tricky month to navigate.
The bears will be out in full force -- but this market is all about second- and third-level thinking, so make sure you question simplistic arguments.
Cement stocks will be big beneficiaries of the Chinese administration's infrastructure growth plans.
Doctor Copper is still a harbinger of global economic health -- keep a close eye on copper prices as the trade war marches on.
Equity markets can continue to move up and regain lost performance -- valuations are supportive and company's earnings are not as bad as feared.
Nippon Parking Development Co. is still a force in parking, but it's also an operator of prime ski resorts in Japan that have become a magnet for skiers throughout Asia.